Cancer Genetics Stock News

Gainers Immunomedics, Inc. (NASDAQ: IMMU) shares jumped 99.8% to close at $18.78 on Monday after the company said it would stop its Ascent Study due to compelling evidence of...

Gainers Immunomedics, Inc. (NASDAQ: IMMU) shares climbed 103.7% to $19.15 after the company said it would stop its Ascent Study due to compelling evidence of efficacy. TPG RE...

Dublin, April 06, 2020 -- The "U.S. Hematologic Malignancies Testing Market: Focus on Product, Disease, Technology, End User, Country Data and Competitive Landscape -.

Gainers BioSig Technologies, Inc. (NASDAQ: BSGM) shares gained 42.4% to close at $5.14 on Friday. BioSig is expected to host telebriefing on development updates regarding...

U. S. Hematologic Malignancies Market to Reach $1,827 Million by 2025. Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the U. • What

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares surged 84% to $3.3525 following news Phase 2b study results for its sofpironium bromide hyperhidrosis treatment were published...

RUTHERFORD, N.J., Feb. 20, 2020 -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and.

Gainers Schrodinger, Inc. (NASDAQ: SDGR) shares jumped 68.5% to close at $28.64 on Thursday after the company priced its IPO at $17 per share. Yield10 Bioscience, Inc. (NASDAQ:...